Conversely, most adenocarcinomas, such as colon (COAD, blue) and pancreatic adenocarcinomas (PAAD, black) had a low prevalence of KRAS A146 mutations and were not responsive to LZTR1 knockout in DepMap (Fig. 4I). This evidence concerns the gene KRAS and adenocarcinoma.